Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer

Whether ICIs combined with chemotherapy can improve outcomes in EGFR-mutant non-small cell lung cancer (NSCLC) remains uncertain. Patients with EGFR-mutant NSCLC and who progressed on first-line EGFR-TKIs treatment were retrospectively collected. We reviewed the outcome of these patients treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chia-I, Chao, Heng-Sheng, Shiao, Tsu-Hui, Chiang, Chi-Lu, Huang, Hsu-Ching, Luo, Yung-Hung, Chiu, Chao-Hua, Chen, Yuh-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352947/
https://www.ncbi.nlm.nih.gov/pubmed/34373555
http://dx.doi.org/10.1038/s41598-021-95628-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352947/
https://www.ncbi.nlm.nih.gov/pubmed/34373555
http://dx.doi.org/10.1038/s41598-021-95628-w

Ejemplares similares